Critically, despite the small cohort size, we have also identified cancer-associated genes that are recurrently mutated in AS, but not previously reported as such in canine HSA, including ATRX, FAT1, GRIN2A and RELN, further strengthening the support for canine HSA as a relevant model for AS in humans. The gene discussed is RELN; the disease is cancer.